Form 4: BioSig Technologies Director Frederick Hrkac Acquires 30,000 Shares of Common Stock

Director Frederick Hrkac acquired 30,000 shares of BioSig Technologies common stock on July 26, 2024, as a grant for services.

Summary

• On July 26, 2024, Frederick Hrkac, a director of BioSig Technologies, Inc., acquired 30,000 shares of common stock.
• The acquisition was a grant for services, with the shares fully vested on the date of the grant.
• The price per share was $0, based on a closing price of $0.41 per share.
• Following the transaction, Hrkac's direct ownership increased to 589,501 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by a director. The grant of shares for services is a moderately positive signal, suggesting alignment of interests.

Positives

• A director receiving shares for services can be seen as a positive sign, aligning the director's interests with the company's success.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director, buys or sells shares of the company's stock. It provides transparency to the market regarding insider transactions.

Stakeholder Impact

• The acquisition of shares by a director could be viewed positively by shareholders, as it demonstrates confidence in the company.

Key Dates